Join to view full profile
5 E 98th StNew York, NY 10029
Phone+1 212-241-4299
Fax+1 212-426-5099
Dr. Mehandru is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
BronxCare Health SystemResidency, Gastroenterology, 2016 - 2022- Rockefeller University HospitalPost-Doctoral Fellowship, 2009 - 2012
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2007 - 2010- Rockefeller University HospitalPost-Doctoral Fellowship, 2003 - 2006
NYU Grossman School of MedicineChief Residency, Internal Medicine, 2002 - 2003
Certifications & Licensure
NY State Medical License 2007 - 2028
AL State Medical License 2002 - 2007
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Viral and Host Factors in the Transmission and Pathogenesis of HIV Start of enrollment: 2000 Jul 01
- Phase I/II, Open-Label Trial of Three Monoclonal Antibodies Start of enrollment: 2003 Oct 01
Publications & Presentations
PubMed
- Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.Arno R Bourgonje, Gabriel Innocenti, Alexandra E Livanos, Melanie Prinzensteiner, Jared S Magee
Gut. 2026-07-23 - Establishing a flow cytometry-based tissue receptor occupancy assay for an anti-oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease.Divya Jha, Hailey Garma, Sean Lear, Aaron Schroeder, Olusegun Onabajo
Cytometry. Part B, Clinical Cytometry. 2026-07-01 - Engineering immune cell therapies for inflammatory bowel disease: from stem cells to CAR T cells.Markus F Neurath, Raja Atreya, Jean-Frederic Colombel, Saurabh Mehandru
Nature Reviews. Gastroenterology & Hepatology. 2026-06-30
Press Mentions
We May Finally Know Why Psychological Stress Worsens Gut InflammationMay 26th, 2023- Long COVID-19 Patients More Likely to Have Gastrointestinal Problems, Study FindsMarch 8th, 2023
- Long Covid Patients More Likely to Have Gastrointestinal Problems, Study FindsMarch 7th, 2023
Grant Support
- Training Program in Investigative Gastroenterology and HepatologyICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
- Decoding mutualistic microbiota-B cell interactions in the HIV-1-infected gut: impact on immunological non-respondersICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
